Mostrando 1,181 - 1,200 Resultados de 311,078 Para Buscar '"COM"', tiempo de consulta: 0.68s Limitar resultados
  1. 1181
  2. 1182
  3. 1183
  4. 1184
  5. 1185
    “…Além disso, observamos que os níveis de HO-1 na admissão estão positivamente correlacionados com parâmetros da hemostasia como TP, TTPa, fibrinogênio, FVIII:C, FVW:Ag e receptor de uroquinase (u-PAR), mas não apresentam associação evidente com parâmetros clínicos de gravidade. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 1186
  7. 1187
  8. 1188
  9. 1189
  10. 1190
    “…Foram feitas análises descritivas da amostra com base em frequências absolutas e relativas. RESULTADOS: Foram analisados 998 pacientes, com suspeita de aspergilose em 72 pacientes. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 1191
  12. 1192
    “…Existem poucos dados no Brasil sobre a epidemiologia das ICS em pacientes com COVID-19 internados em UTI. OBJETIVO: Descrever a epidemiologia, a microbiologia e o desfecho clínico dos pacientes com COVID-19 que desenvolveram ICS internados nas UTIs. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 1193
  14. 1194
    “…Eighteen themes were identified and mapped directly on to the six COM-B constructs. The most reported barriers to using the physical activity referral scheme related to the opportunity construct of the COM-B model, specifically childcare responsibilities, work commitments and environmental barriers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 1195
  16. 1196
  17. 1197
    “…DESIGN: We used two implementation science models, the Capability, Opportunity and Behaviour Model (COM-B) and the Theoretical Domains Framework, to code interviews with hospital staff, and an implementation process, the Behaviour Change Wheel (BCW), to codevelop potential interventions with stakeholders from each clinician group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 1198
    por Jones, Glenn R.
    Publicado 1999
    Libro
  19. 1199
    “…This report aims to understand the persistence of immune response to the viral vectored, mRNA and protein-based COVID-19 vaccine platforms used in homologous and heterologous priming combinations, which will inform the choice of vaccine platform in future vaccine development. METHODS: Com-COV2 was a single-blinded trial in which adults ≥ 50 years, previously immunised with single dose ‘ChAd’ (ChAdOx1 nCoV-19, AZD1222, Vaxzevria, Astrazeneca) or ‘BNT’ (BNT162b2, tozinameran, Comirnaty, Pfizer/BioNTech), were randomised 1:1:1 to receive a second dose 8–12 weeks later with either the homologous vaccine, or ‘Mod’ (mRNA-1273, Spikevax, Moderna) or ‘NVX’ (NVX-CoV2373, Nuvaxovid, Novavax). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 1200
    “…The synthesis of the integrated Promoting Action on Research Implementation in Health Services (iPARIHS) and Capability, Opportunity, Motivation and Behaviour (COM-B) frameworks led to an evolved framework bringing together important implementation and behaviour change elements which will be used as a basis for the study process evaluation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS